Phase 1 dose-expansion study of pegylated arginine deiminase, cisplatin, and pemetrexed in patients with argininosuccinate synthetase 1 (ASS1)-deficient non-squamous non-small cell lung cancer.

被引：0
|
作者：
Wimalasingham, Akhila Ganeshi
Phillips, Melissa Mary
Lim, Louise
Rashid, Sukaina
Hall, Peter Edward
Khadeir, Ramsay
Steele, Jeremy P. C.
Conibear, John
Feng, Xiaoxing
Ellis, Stephen
Chan, Pui Ying
Thomson, Jim
Johnston, Amanda L.
Bomalaski, John S.
Pacey, Simon
Sheaff, Michael
Szlosarek, Peter Wojciech
机构：
[1] Barts Hlth NHS Trust, London, England
[2] Barts Canc Inst, London, England
[3] Queen Mary Univ London, London, England
[4] St Bartholomews Hosp, London, England
[5] Washington State Univ, Pullman, WA 99164 USA
[6] Barts Hlth Trust, London, England
[7] Polaris Pharmaceut Inc, San Diego, CA USA
[8] Agouron Pfizer, San Diego, CA USA
[9] Univ Cambridge, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9097
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [32] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Nakagawa, Hiroaki
    Tomii, Keisuke
    Okada, Asuka
    Yoshimura, Kenichi
    Hirabayashi, Masataka
    Hirai, Toyohiro
    ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
  • [33] Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1-Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms
    Szlosarek, Peter W.
    Phillips, Melissa M.
    Pavlyk, Iuliia
    Steele, Jeremy
    Shamash, Jonathan
    Spicer, James
    Kumar, Sanjeev
    Pacey, Simon
    Feng, Xiaoxing
    Johnston, Amanda
    Bomalaski, John
    Moir, Graeme
    Lau, Kelvin
    Ellis, Stephen
    Sheaff, Michael
    JTO CLINICAL AND RESEARCH REPORTS, 2020, 1 (04):
  • [34] Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
    Yokoi, Takashi
    Torii, Yoshitaro
    Katashiba, Yuichi
    Sugimoto, Hiroyuki
    Tanijiri, Tsutomu
    Ogata, Makoto
    Inagaki, Noriko
    Kibata, Kayoko
    Hayashi, Mina
    Niki, Maiko
    Shimizu, Toshiki
    Miyara, Takayuki
    Kurata, Takayasu
    Nomura, Shosaku
    ONCOLOGY LETTERS, 2014, 8 (06) : 2453 - 2457
  • [35] A phase 1b/2 study of napabucasin with weekly paclitaxel in advanced, previously treated non-squamous non-small cell lung cancer.
    Becerra, Carlos
    Hanna, Wahid Tewfik
    Richey, Stephen Lane
    Cote, Gregory Michael
    Laurie, Scott Andrew
    Langleben, Adrian
    Gao, Yuan
    Li, Wei
    Li, Youzhi
    Hitron, Matthew
    Li, Chiang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] A Phase I Study of Exemestane with Carboplatin and Pemetrexed in Postmenopausal Women with Metastatic, Non-Squamous Non-Small Cell Lung Cancer
    Pietras, Richard
    Goldman, Jonathan W.
    Marquez-Garban, Diana C.
    Wong, Deborah J. L.
    Applebaum, Steven
    Mendenhall, Melody
    Ledezma, Blanca A.
    Wolf, Brian
    Adame, Carlos R.
    Rosales, Sarah
    Paroly, Jill
    Paiz, Sebastian
    Nameth, Danielle
    Spiegel, Marshall L.
    Hecht, Naomi
    Brennan, Meghan
    Dubinett, Steven M.
    Garon, Edward B.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S667 - S667
  • [37] Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients
    Chen, Yongshun
    Wen, Qinglian
    Liu, Hao
    Ao, Rui
    Wu, Xiaoyuan
    Guo, Leiming
    Wang, Wen
    He, Chunyu
    Wang, Jianhua
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 553 - 557
  • [38] Erlotinib versus Pemetrexed for Pretreated Non-Squamous Non-Small Cell Lung Cancer Patients in Clinical Practice
    Zugazagoitia, J.
    Puente, J.
    Gonzalez-Larriba, J. L.
    Manzano, A.
    Sotelo, M.
    Hernandez, S.
    Sanz, J.
    Perez, P.
    Diaz-Rubio, E.
    ONCOLOGY, 2013, 84 (05) : 255 - 264
  • [39] Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer
    Toshirou Fukushima
    Yuuki Wakatsuki
    Takashi Kobayashi
    Kei Sonehara
    Kazunari Tateishi
    Manabu Yamamoto
    Takeshi Masubuchi
    Fumiaki Yoshiike
    Kazuya Hirai
    Tsutomu Hachiya
    Tomonobu Koizumi
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 1043 - 1050
  • [40] Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer
    Fukushima, Toshirou
    Wakatsuki, Yuuki
    Kobayashi, Takashi
    Sonehara, Kei
    Tateishi, Kazunari
    Yamamoto, Manabu
    Masubuchi, Takeshi
    Yoshiike, Fumiaki
    Hirai, Kazuya
    Hachiya, Tsutomu
    Koizumi, Tomonobu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (06) : 1043 - 1050
12345